Bei Akademie registrieren
Stryker Corp., US8636671013

Stryker stock trades at EUR 261.55 as Stryker announces CMR alliance

Published on 10/18/2026 at 17:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Stryker agrees to invest $400 million in CMR Surgical. Stryker stock is EUR 261.55 in weekend trading on October 18, 2026 versus the EUR 261.50 Xetra close.

Alliance And Trading Context

  • Stryker announced an approximately $400 million CMR Surgical investment on October 12, 2026.
  • Stryker stock trades in weekend trading at EUR 261.55 at 5:34 p.m. CEST on October 18, 2026, 0.02 percent above the Xetra close of October 16, 2026.
  • The next Xetra session is scheduled for October 19, 2026.
Flatlay mit Aktienzertifikat, ISIN-Karte, Stethoskop und orthopädischem Implantatmodell
Flatlay-Arrangement mit Aktienzertifikat und ISIN-Karte US8636671013 illustriert eine Investition in Stryker Corp. Medizintechnik-Aktien, Illustration mit AI erstellt.

Stryker stock trades in weekend trading at Lang & Schwarz at EUR 261.55 at 5:34 p.m. CEST on October 18, 2026, 0.02 percent above the Xetra close of October 16, 2026 at EUR 261.50. Separately, Stryker Corporation announced on October 12, 2026, that it would make an approximately $400 million preferred equity investment in CMR Surgical and receive an exclusive option to acquire the company’s outstanding equity, subject to the agreement’s terms and customary closing conditions, according to GlobeNewswire.

Market context: Market report S&P 500.

The week in figures

Lang & Schwarz showed EUR 261.55 for Stryker in weekend trading at 5:34 p.m. CEST on October 18, 2026. The price was EUR 0.05, or 0.02 percent, above the Xetra close of October 16, 2026 at EUR 261.50.

The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Stryker stock.

Chronology of the week

On October 12, 2026, Stryker and CMR Surgical announced a strategic alliance covering an approximately $400 million preferred equity investment, an exclusive option to acquire CMR Surgical’s outstanding equity and exclusive U.S. sales rights for the Versius surgical robotics portfolio. CMR Surgical will continue to lead portfolio development and commercialization outside the United States, according to GlobeNewswire.

Dates of the coming week

The next Xetra session is scheduled for October 19, 2026. Stryker’s third-quarter 2026 results are scheduled for October 29, 2026.

Disclaimer...
en | US8636671013 | STRYKER CORP. | boerse | 70354835 | bgmi